Isomorphic Labs

Company facts

• Founded

  2021

  ConfirmedSource for founded (opens in new tab)

• Headquarters

  United Kingdom (London)

  ConfirmedSource for headquarters (opens in new tab)

• Total funding

  $2.7B

  ConfirmedSource for total funding (opens in new tab)

Latest funding round

Drug discovery partners

3 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

• Johnson & Johnson Pharma

  Research collaboration, Jan 20, 2026

  Terms not disclosed

  ConfirmedSource for Johnson & Johnson (opens in new tab)

• Eli Lilly Pharma

  Research collaboration, Jan 7, 2024

  $45M upfront ($1.75B total potential)

  ConfirmedSource for Eli Lilly (opens in new tab)

• Novartis Pharma

  Research collaboration, Jan 7, 2024

  $37.5M upfront ($1.24B total potential)

  ConfirmedSource for Novartis (opens in new tab)

Big tech ties

Not counted as pharma partners.

• Alphabet (including GV, CapitalG)

  Parent and Series B investor

  ConfirmedSource for Alphabet (including GV, CapitalG) (opens in new tab)

Recent news

• Oct 8, 2026

  Early talks at $40B to $50B valuation; first human trials targeted late 2026

  ReportedSource (opens in new tab)

• Sep 29, 2026

  Unveiled IsoDDE drug design engine

  ReportedSource (opens in new tab)

• May 12, 2026

  Series B: $2.1B

  ConfirmedSource (opens in new tab)

• Jan 20, 2026

  Cross-modality, multi-target research collaboration with Johnson & Johnson

  ConfirmedSource (opens in new tab)

• Mar 31, 2025

  Raised $600M first external round (official)

  ConfirmedSource (opens in new tab)